Trailing-twelve-month (TTM) revenue is $4.07 Million with a year-over-year growth of (0.40%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,051,165 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-14 |
| Q4 FY2025Period ended 2025-12-31 | $613,708 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-06-30 |
| Q1 FY2026Period ended 2026-03-31 | $285,313 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-31 |
| Q2 FY2026Period ended 2026-06-30 | $2,118,355 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-19 |
| TTM revenue | $4,068,541 |
Current P/S: $711,068 market capitalization ÷ $4,068,541 TTM revenue = 0.17x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:00.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $2.12M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T21:37:56.548Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2024-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD |
|---|---|---|---|---|---|---|
| Government Contract | N/A | $751,697 | $2M | $905,554 | $1M | N/A |
| Hospitality | N/A | $487,111 |
$4.07M
$4.07 Million
(0.40%)
vs. $4.08M a year ago (TTM)
(32.47%)
5 Year compound annual growth rate
1 Year
(0.40%)
3 Year
(39.99%)
5 Year
(32.47%)
10 Year
+9.84%
15 Year
+3.05%
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.95M | ($2.02M) | (40.68%) |
| 2024 | $4.98M | ($11.55M) | (69.88%) |
| 2023 | $16.52M | ($7.87M) | (32.27%) |
| 2022 | $24.39M | ($13.95M) | (36.38%) |
| 2021 | $38.34M | +$29.59M | +337.91% |
| 2020 |
TTM Growth
(0.40%)
3-Year CAGR
(39.99%)
5-Year CAGR
(32.47%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T21:37:56.548Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| $3M |
| $250,450 |
| $181,719 |
| Medical (LAX lab testing) | N/A | $4M | N/A | N/A | N/A | N/A |
|---|
| Medical (modular structures) | N/A | $778,883 | N/A | N/A | N/A | N/A |
|---|
| Medical Construction Services | N/A | N/A | $495,122 | N/A | N/A | N/A |
|---|
| Multi Families | $94,178 | $126,222 | $103,672 | $86,033 | N/A | N/A |
|---|
| Office | $1M | $191,505 | $534,001 | $9M | $15M | $5M |
|---|
| Product and Service, Other | $1,442 | $300,000 | N/A | N/A | N/A | N/A |
|---|
| Retail | $1M | $427,444 | $285,177 | $5,344 | N/A | N/A |
|---|
| School | N/A | $36,500 | N/A | N/A | N/A | N/A |
|---|
| Special Use | $6,812 | $1M | $2M | $14,640 | $315,426 | N/A |
|---|
| $8.76M |
| +$5.77M |
| +193.34% |
| 2019 | $2.98M | ($5.21M) | (63.56%) |
| 2018 | $8.19M | +$3.13M | +61.81% |
| 2017 | $5.06M | +$795,000 | +18.63% |
| 2016 | $4.27M | +$1.86M | +77.35% |
